Literature DB >> 17114882

Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease.

J H Park1, S B Lee, T J Lee, D Y Lee, J H Jhoo, J C Youn, I H Choo, E A Choi, J W Jeong, J Y Choe, J I Woo, K W Kim.   

Abstract

BACKGROUND/AIMS: To compare the prevalence and characteristics of depression in vascular dementia (VaD) and Alzheimer's disease (AD) after adjusting for dementia severity and gender.
METHODS: One hundred and eight pairs of VaD and AD patients matched for dementia severity and gender were assessed.
RESULTS: Major depressive disorder (MDD) was more prevalent in the VaD group than in the AD group (20.4% in VaD, 10.2% in AD, p = 0.04, Cochran-Mantel-Haenszel, CMH, test) regardless of the dementia severity and gender. The odds ratio for developing MDD in the VaD group versus the AD group was estimated to be 2.20 (95% confidence interval = 1.02-4.74). Neurovegetative symptoms such as 'felt tired and weak all the time' (30.6% in VaD, 13.9% in AD, p = 0.003, CMH test) and 'changed weight without trying' (16.7% in VaD, 6.5% in AD, p = 0.02, CMH test) were more prevalent in the VaD group than in the AD group.
CONCLUSION: Depression in VaD was quantitatively and qualitatively different from that in AD regardless of the severity of dementia and gender; depression was more prevalent, severer and more retarded and vegetative in VaD than in AD. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 17114882     DOI: 10.1159/000097039

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  21 in total

Review 1.  Transforming mental health services to address gender disparities in depression risk factors.

Authors:  Karen Whiteman; Nicole Ruggiano; Barbara Thomlison
Journal:  J Women Aging       Date:  2016-07-08

Review 2.  Depression in older adults.

Authors:  Amy Fiske; Julie Loebach Wetherell; Margaret Gatz
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

3.  Prevalence of depression among older Americans: the Aging, Demographics and Memory Study.

Authors:  David C Steffens; Gwenith G Fisher; Kenneth M Langa; Guy G Potter; Brenda L Plassman
Journal:  Int Psychogeriatr       Date:  2009-06-12       Impact factor: 3.878

4.  Comparing the effect of the novel ionic cocrystal of lithium salicylate proline (LISPRO) with lithium carbonate and lithium salicylate on memory and behavior in female APPswe/PS1dE9 Alzheimer's mice.

Authors:  Ahsan Habib; R Douglas Shytle; Darrell Sawmiller; Selina Koilraj; Sadia Afrin Munna; David Rongo; Huayan Hou; Cesario V Borlongan; Glenn Currier; Jun Tan
Journal:  J Neurosci Res       Date:  2019-05-17       Impact factor: 4.164

5.  Incident depression and mortality among people with different types of dementia: results from a longitudinal cohort study.

Authors:  Laura Perna; H W Wahl; J Weberpals; L Jansen; U Mons; B Schöttker; H Brenner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-03-06       Impact factor: 4.328

Review 6.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

7.  Physicians' detection of late-life depression: the roles of dysphoria and cognitive impairment.

Authors:  Jeffrey J Gregg; Amy Fiske; Margaret Gatz
Journal:  Aging Ment Health       Date:  2013-06-14       Impact factor: 3.658

8.  Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia.

Authors:  Deborah E Barnes; Kristine Yaffe; Amy L Byers; Mark McCormick; Catherine Schaefer; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2012-05

9.  Depressive symptoms, vascular risk factors, and Alzheimer's disease.

Authors:  José A Luchsinger; Lawrence S Honig; Ming-Xin Tang; Devangere P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2008-09       Impact factor: 3.485

Review 10.  Pathways linking late-life depression to persistent cognitive impairment and dementia.

Authors:  Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.